Daniel George, MD
Duke University · Duke Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Daniel George, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:41 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06603155 · Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)Duke University · withdrawn · Metastatic Head-and-neck Squamous-cell Carcinoma, Unresectable Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma · principal investigator
- N/ANCT04919122 · Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell CarcinomaDuke University · active not recruiting · Metastatic Renal Cell Carcinoma · principal investigator
- Ph2NCT04569461 · Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)Duke University · withdrawn · Prostate Cancer · principal investigator
- N/ANCT03151629 · International Registry for Men With Advanced Prostate Cancer (IRONMAN)Prostate Cancer Clinical Trials Consortium · recruiting · Prostate Cancer · principal investigator
- N/ANCT02978118 · Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)Duke University · active not recruiting · Carcinoma, Renal Cell, Carcinoma, Urothelial · principal investigator
- Ph1NCT02963051 · A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate CancerDaniel George, MD · terminated · Prostate Cancer · principal investigator
- Ph2NCT01940276 · Abiraterone Race in Metastatic Castrate-resistant Prostate CancerDuke University · completed · Prostate Cancer · principal investigator
- Ph2NCT01717053 · Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate CancerDuke University · completed · Prostate Cancer · principal investigator
- Ph2NCT00918385 · Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate CancerDuke University · terminated · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.